Paper30669
Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
Sharon P and 3 others. Gastroenterology, 1978. Cited by 467 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Papers, record 30669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30669
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colitis, Ulcerative | Major topic |
| Intestinal Mucosa | Major topic |
| Prostaglandins E | Major topic |
| Sulfasalazine | Major topic |
| Aminosalicylic Acids | |
| Culture Techniques | |
| Depression, Chemical | |
| Humans | |
| Rectum | |
| Sulfapyridine |
Source PubMed
Cited by146
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 467 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41687611 | Engineered intestinal crypt geometry uncovers YAP1-dependent fetal-to-adult transition. | Cell Stem Cell | 2026 | https://conductscience.org/library/papers/41687611 | PubMed |
| 41471365 | Safety, Pharmacokinetics, and Bioequivalence Characterization of Two Different Strengths of Mesalazine Gastro-Resistant Tablets. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471365 | PubMed |
| 41065754 | Cytokine-Induced Barrier Dysfunction and Lipid Signaling in a Gut-On-Chip Model. | FASEB J | 2025 | https://conductscience.org/library/papers/41065754 | PubMed |
| 40790908 | Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems. | Drug Deliv | 2025 | https://conductscience.org/library/papers/40790908 | PubMed |
| 39616171 | Costunolide and dehydrocostus lactone alleviate ulcerative colitis via regulating TLR4, NF-κB and PI3K expression. | Sci Rep | 2024 | https://conductscience.org/library/papers/39616171 | PubMed |
| 39596393 | Microsomal Prostaglandin E Synthase-1 Controls Colonic Prostaglandin E2 Production and Exerts a Protective Effect on Colitis Induced by Trinitrobenzene Sulfonic Acid in Mice. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596393 | PubMed |
| 39352537 | 5-aminosalicylic acid alleviates colitis and protects intestinal barrier function by modulating gut microbiota in mice. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39352537 | PubMed |
| 37719567 | Mesalamine - A Revered Drug for Inflammatory Bowel Disease With Detrimental Effects on the Lung and Heart. | Cureus | 2023 | https://conductscience.org/library/papers/37719567 | PubMed |
| 37525068 | The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial. | Eur J Nutr | 2023 | https://conductscience.org/library/papers/37525068 | PubMed |
| 37190315 | Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190315 | PubMed |
| 37056732 | Crosstalk between omega-6 oxylipins and the enteric nervous system: Implications for gut disorders? | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37056732 | PubMed |
| 36432460 | The Role of Dietary Fibers in the Management of IBD Symptoms. | Nutrients | 2022 | https://conductscience.org/library/papers/36432460 | PubMed |
| 34983695 | Facilitation of colonic T cell immune responses is associated with an exacerbation of dextran sodium sulfate-induced colitis in mice lacking microsomal prostaglandin E synthase-1. | Inflamm Regen | 2022 | https://conductscience.org/library/papers/34983695 | PubMed |
| 34941734 | Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet? | Toxins (Basel) | 2021 | https://conductscience.org/library/papers/34941734 | PubMed |
| 34063522 | Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products. | Biomolecules | 2021 | https://conductscience.org/library/papers/34063522 | PubMed |
| 33805551 | Mechanism of Na-K-ATPase Inhibition by PGE2 in Intestinal Epithelial Cells. | Cells | 2021 | https://conductscience.org/library/papers/33805551 | PubMed |
| 33468700 | 5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium. | mBio | 2021 | https://conductscience.org/library/papers/33468700 | PubMed |
| 33419109 | Anti-Inflammatory Activity and Mechanism of Isookanin, Isolated by Bioassay-Guided Fractionation from Bidens pilosa L. | Molecules | 2021 | https://conductscience.org/library/papers/33419109 | PubMed |
| 32164249 | Altered Structural Expression and Enzymatic Activity Parameters in Quiescent Ulcerative Colitis: Are These Potential Normalization Criteria? | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32164249 | PubMed |
| 31645712 | Epithelial EP4 plays an essential role in maintaining homeostasis in colon. | Sci Rep | 2019 | https://conductscience.org/library/papers/31645712 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30669
GET https://conductscience.org/api/papers/v1/30669/cited_by?page=2